Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Sep-24 6:49 PM View:  | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-24 | Payment of Exercise | 826 | $15.13 | $12,494.10 | (< 1%) 326.58K to 325.75K | |
| 05-Sep-24 6:49 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Sep-24 | Payment of Exercise | 4,744 | $15.42 | $73,168.60 | (1%) 331.32K to 326.58K | |
| 05-Sep-24 6:49 PM View: | Entrada Therapeutics, Inc. (TRDA) | 03-Sep-24 | Payment of Exercise | 3,152 | $16.08 | $50,694.40 | (< 1%) 334.48K to 331.32K | |
| 16-Jul-24 4:42 PM View: | Entrada Therapeutics, Inc. (TRDA) | 15-Jul-24 | Sale (Planned) | 1,600 | $17.81 | $28,497.30 | (< 1%) 336.07K to 334.48K | |
| 16-Jul-24 4:42 PM View: | Entrada Therapeutics, Inc. (TRDA) | 12-Jul-24 | Private Sale (Planned) | 300 | $18.00 | $5,400.00 | (< 1%) 336.38K to 336.07K | |
| 14-Jun-24 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 13-Jun-24 | Private Sale (Planned) | 1,000 | $16.17 | $16,173.60 | (< 1%) 337.38K to 336.38K | |
| 20-May-24 5:21 PM View: | Entrada Therapeutics, Inc. (TRDA) | 17-May-24 | Sale (Planned) | 1,200 | $15.11 | $18,129.10 | (< 1%) 338.57K to 337.38K | |
| 20-May-24 5:21 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-May-24 | Private Sale (Planned) | 1,800 | $15.00 | $27,000.00 | (< 1%) 340.38K to 338.57K | |
| 05-Mar-24 7:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Mar-24 | Payment of Exercise | 5,049 | $12.28 | $61,995.70 | (1%) 345.42K to 340.38K | |
| 05-Mar-24 7:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 04-Mar-24 | Payment of Exercise | 2,555 | $12.94 | $33,054.30 | (< 1%) 347.98K to 345.42K | |
| 05-Mar-24 7:48 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-24 | Grant | 104,700 | -- | -- | 43% 243.28K to 347.98K | |
| 20-Feb-24 4:37 PM View: | Entrada Therapeutics, Inc. (TRDA) | 15-Feb-24 | Private Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (< 1%) 244.28K to 243.28K | |
| 18-Jan-24 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 16-Jan-24 | Private Sale (Planned) | 1,000 | $15.99 | $15,990.00 | (< 1%) 245.28K to 244.28K | |
| 22-Dec-23 4:38 PM View: | Entrada Therapeutics, Inc. (TRDA) | 20-Dec-23 | Private Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (< 1%) 246.28K to 245.28K | |
| 13-Nov-23 4:35 PM View: | Entrada Therapeutics, Inc. (TRDA) | 13-Nov-23 | Private Sale (Planned) | 1,000 | $16.23 | $16,230.00 | (< 1%) 247.28K to 246.28K | |
| 19-Oct-23 5:27 PM View: | Entrada Therapeutics, Inc. (TRDA) | 17-Oct-23 | Private Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (< 1%) 248.28K to 247.28K | |
| 15-Sep-23 4:21 PM View: | Entrada Therapeutics, Inc. (TRDA) | 13-Sep-23 | Private Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (< 1%) 249.28K to 248.28K | |
| 06-Sep-23 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 05-Sep-23 | Payment of Exercise | 1,440 | $14.46 | $20,826.00 | (< 1%) 250.72K to 249.28K | |
| 06-Sep-23 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-23 | Grant | 49,650 | -- | -- | 25% 201.07K to 250.72K | |
| 16-Aug-23 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 14-Aug-23 | Private Sale (Planned) | 1,000 | $15.67 | $15,671.30 | (< 1%) 202.07K to 201.07K | |
| 01-May-23 4:38 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Apr-23 | Private Sale (Planned) | 2,000 | $13.71 | $27,421.80 | (< 1%) 204.07K to 202.07K | |
| 19-Apr-23 6:07 PM View: | Entrada Therapeutics, Inc. (TRDA) | 17-Apr-23 | Private Sale (Planned) | 2,092 | $18.01 | $37,675.20 | (1%) 206.16K to 204.07K | |
| 29-Mar-23 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Mar-23 | Private Sale (Planned) | 2,000 | $14.72 | $29,435.30 | (< 1%) 257.81K to 255.81K | |
| 03-Mar-23 4:34 PM View: | Entrada Therapeutics, Inc. (TRDA) | 02-Mar-23 | Payment of Exercise | 3,324 | $11.60 | $38,545.80 | (1%) 261.13K to 257.81K | |
| 03-Mar-23 4:34 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Mar-23 | Grant | 99,300 | -- | -- | 61% 161.84K to 261.13K | |
| 02-Mar-23 4:36 PM View: | Entrada Therapeutics, Inc. (TRDA) | 28-Feb-23 | Market Sale (Planned) | 2,000 | $12.00 | $24,000.00 | (1%) 163.84K to 161.84K | 7% |
| 30-Jan-23 4:32 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Jan-23 | Market Sale (Planned) | 2,000 | $12.00 | $24,001.00 | (1%) 165.84K to 163.84K | 7% |
| 10-Jan-23 4:40 PM View: | Entrada Therapeutics, Inc. (TRDA) | 09-Jan-23 | Private Sale (Planned) | 2,410 | $15.02 | $36,195.50 | (1%) 168.25K to 165.84K | |
| 29-Dec-22 4:51 PM View: | Entrada Therapeutics, Inc. (TRDA) | 29-Dec-22 | Sale (Planned) | 400 | $15.01 | $6,005.12 | (< 1%) 168.65K to 168.25K | |
| 29-Dec-22 4:51 PM View: | Entrada Therapeutics, Inc. (TRDA) | 28-Dec-22 | Sale (Planned) | 4,521 | $15.01 | $67,851.60 | (3%) 173.17K to 168.65K | |
| 29-Dec-22 4:51 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Dec-22 | Private Sale (Planned) | 9,669 | $15.02 | $145,263.00 | (5%) 182.84K to 173.17K | |
| 30-Nov-22 4:31 PM View: | Entrada Therapeutics, Inc. (TRDA) | 28-Nov-22 | Private Sale (Planned) | 2,000 | $13.91 | $27,826.20 | (1%) 184.84K to 182.84K | |
| 27-Oct-22 6:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Oct-22 | Sale (Planned) | 2,000 | $21.66 | $43,325.00 | (1%) 186.84K to 184.84K | |
| 27-Oct-22 6:46 PM View: | Entrada Therapeutics, Inc. (TRDA) | 25-Oct-22 | Private Sale (Planned) | 12,061 | $20.66 | $249,187.00 | (6%) 198.9K to 186.84K | |
| 24-Oct-22 5:10 PM View: | Entrada Therapeutics, Inc. (TRDA) | 24-Oct-22 | Sale (Planned) | 2,342 | $19.30 | $45,189.00 | (1%) 201.24K to 198.9K | |
| 24-Oct-22 5:10 PM View: | Entrada Therapeutics, Inc. (TRDA) | 21-Oct-22 | Sale (Planned) | 2,786 | $18.28 | $50,916.70 | (1%) 204.02K to 201.24K | |
| 24-Oct-22 5:10 PM View: | Entrada Therapeutics, Inc. (TRDA) | 20-Oct-22 | Private Sale (Planned) | 811 | $18.01 | $14,607.20 | (< 1%) 204.84K to 204.02K | |
| 28-Sep-22 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 28-Sep-22 | Sale (Planned) | 3,085 | $15.23 | $46,996.60 | (1%) 207.92K to 204.84K | |
| 28-Sep-22 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Sep-22 | Sale (Planned) | 4,419 | $15.21 | $67,219.80 | (2%) 212.34K to 207.92K | |
| 28-Sep-22 5:12 PM View: | Entrada Therapeutics, Inc. (TRDA) | 26-Sep-22 | Private Sale (Planned) | 3,083 | $15.32 | $47,225.30 | (1%) 215.42K to 212.34K | |
| 23-Sep-22 4:59 PM View: | Entrada Therapeutics, Inc. (TRDA) | 23-Sep-22 | Sale (Planned) | 1,023 | $15.07 | $15,412.50 | (< 1%) 216.44K to 215.42K | |
| 23-Sep-22 4:59 PM View: | Entrada Therapeutics, Inc. (TRDA) | 21-Sep-22 | Private Sale (Planned) | 3,402 | $15.12 | $51,425.30 | (2%) 219.85K to 216.44K | |
| 19-Sep-22 4:35 PM View: | Entrada Therapeutics, Inc. (TRDA) | 15-Sep-22 | Private Sale (Planned) | 200 | $15.04 | $3,008.00 | (< 1%) 220.05K to 219.85K | |
| 12-Sep-22 4:21 PM View: | Entrada Therapeutics, Inc. (TRDA) | 09-Sep-22 | Sale (Planned) | 688 | $15.07 | $10,366.00 | (< 1%) 220.74K to 220.05K | |
| 12-Sep-22 4:21 PM View: | Entrada Therapeutics, Inc. (TRDA) | 08-Sep-22 | Private Sale (Planned) | 1,100 | $15.16 | $16,673.50 | (< 1%) 221.84K to 220.74K | |
| 06-Sep-22 4:31 PM View: | Entrada Therapeutics, Inc. (TRDA) | 01-Sep-22 | Grant | 15,125 | -- | -- | 7% 206.71K to 221.84K | |
| 31-Aug-22 4:55 PM View: | Entrada Therapeutics, Inc. (TRDA) | 31-Aug-22 | Sale (Planned) | 171 | $12.00 | $2,052.00 | (< 1%) 206.88K to 206.71K | |
| 31-Aug-22 4:55 PM View: | Entrada Therapeutics, Inc. (TRDA) | 30-Aug-22 | Sale (Planned) | 190 | $12.00 | $2,280.00 | (< 1%) 207.07K to 206.88K | |
| 31-Aug-22 4:55 PM View: | Entrada Therapeutics, Inc. (TRDA) | 29-Aug-22 | Private Sale (Planned) | 1,639 | $12.88 | $21,103.10 | (< 1%) 208.71K to 207.07K | |
| 29-Jul-22 4:03 PM View: | Entrada Therapeutics, Inc. (TRDA) | 27-Jul-22 | Market Sale (Planned) | 2,000 | $12.00 | $24,000.00 | (< 1%) 210.71K to 208.71K | 7% |